CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

The Prognostic Significance of Periprocedural Infarction in the Era of Potent Antithrombotic Therapy: The PRAGUE-18 Substudy Discharge Against Medical Advice After Percutaneous Coronary Intervention in the United States Management of Percutaneous Coronary Intervention Complications: Algorithms From the 2018 and 2019 Seattle Percutaneous Coronary Intervention Complications Conference Long-term outcomes after myocardial infarction in middle-aged and older patients with congenital heart disease-a nationwide study Prevalence and Prognosis of Unrecognized Myocardial Infarction Determined by Cardiac Magnetic Resonance in Older Adults Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC) The Potential Use of the Index of Microcirculatory Resistance to Guide Stratification of Patients for Adjunctive Therapy in Acute Myocardial Infarction The Prognostic Value of Exercise Echocardiography After Percutaneous Coronary Intervention
|<<... 41 42 43 44 45 46 47 ...>>|

JOURNAL： Article Link

南京市第一医院心血管内科为一名难治性高血压患者成功实施肾动脉去交感神经消融术（RDN）

qiaomingyue Keywords: 高血压病被称为“无声的杀手”，全球高血压患者超13亿，而我国患者人数已突破3.4亿，且患病率仍在攀升。在我国3.4亿高血压患者中，近20%为难治性人群。针对高血压防控的难点，南京市第一医院心内科于河西院区成立“高血压中心”，致力于推动高血压诊疗新技术的研发及临床应用。

网站资料更新中...
>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top